Hideshima, Teru
Harvard Medical School,
United States
2025 Rank: 28384
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 921 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28384 | 27242 |
| Total Cites | 40388 | 48619 |
| H-index | 106 | 117 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 8193 | 10002 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 8241 | 10055 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24921 | 26620 |
| Ratio of Total Citations to Distinct Citing Papers | 1.62 | 1.83 |
| Self-Citation Percentage |
16.93%
|
|
Hideshima, Teru
Dana-Farber Cancer Institute,
United States
2024 Rank: 26730
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 893 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26730 | 25264 |
| Total Cites | 39022 | 47194 |
| H-index | 105 | 116 |
| Hm-index | 28 | 29 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 7965 | 9768 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 8013 | 9821 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 23894 | 25561 |
| Ratio of Total Citations to Distinct Citing Papers | 1.63 | 1.85 |
| Self-Citation Percentage |
17.32%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2023 Rank: 25340
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 871 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25340 | 23891 |
| Total Cites | 37614 | 45707 |
| H-index | 103 | 114 |
| Hm-index | 26 | 28 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 7754 | 9553 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 7801 | 9605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22840 | 24484 |
| Ratio of Total Citations to Distinct Citing Papers | 1.65 | 1.87 |
| Self-Citation Percentage |
17.71%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2022 Rank: 23090
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 810 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23090 | 21933 |
| Total Cites | 35876 | 43894 |
| H-index | 101 | 112 |
| Hm-index | 26 | 28 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 7451 | 9249 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 7496 | 9299 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21601 | 23209 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.89 |
| Self-Citation Percentage |
18.27%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2021 Rank: 22425
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 790 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22425 | 21129 |
| Total Cites | 34901 | 42789 |
| H-index | 99 | 110 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 7278 | 9053 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 7322 | 9102 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20962 | 22539 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.90 |
| Self-Citation Percentage |
18.43%
|
|
Hideshima, Teru
Harvard Medical School,
United States
2020 Rank: 20798
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 741 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20798 | 19384 |
| Total Cites | 32826 | 40454 |
| H-index | 95 | 107 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 6966 | 8684 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 7007 | 8730 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 19449 | 20936 |
| Ratio of Total Citations to Distinct Citing Papers | 1.69 | 1.93 |
| Self-Citation Percentage |
18.86%
|
|